Johnson & Johnson vs. Quoin Pharmaceuticals, Ltd. American Depositary Shares
JNJ
Johnson & Johnson
$275.30 -1.12%
VS QNRXQuoin Pharmaceuticals, Ltd. American Depositary Shares
$7.26 -7.75%
Johnson & Johnson (JNJ) comes out ahead, leading on 4 of 5 compared factors.
Size & Scale
| JNJ | QNRX | |
|---|---|---|
| Market Cap | $670.99 billion | $15.81 million |
| Revenue (TTM) | $97.93 billion | — |
| Net Income (TTM) | $21.04 billion | $-18,665,315 |
JNJ leads on 2 of 2 size & scale factors.
Valuation
| JNJ | QNRX | |
|---|---|---|
| P/E Ratio | 31.94 | — |
| Price / Book | 7.90 | 4.02 |
| Price / Sales | 6.85 | — |
QNRX leads on 1 of 1 valuation factors.
Profitability
| JNJ | QNRX | |
|---|---|---|
| Net Margin | 21.48% | — |
| Return on Equity | 24.76% | -474.62% |
JNJ leads on 1 of 1 profitability factors.
Dividend
| JNJ | QNRX | |
|---|---|---|
| Dividend Yield | 1.95% | — |
| Payout Ratio | 62.18 | — |
JNJ and QNRX split the dividend factors evenly.
Risk & Sentiment
| JNJ | QNRX | |
|---|---|---|
| Short Interest | 0.67% | 4.83% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, QNRX overview, QNRX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.